AVNS Avanos Medical, Inc.
Healthcare$24.61-0.36%ClosedMarket Cap: $1.15B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.46
P/S
1.61
EV/EBITDA
-66.22
DCF Value
$-16.94
FCF Yield
0.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.6%
Operating Margin
-7.9%
Net Margin
-9.7%
ROE
-8.9%
ROA
-6.6%
ROIC
-6.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $182.2M | 48.5% | $12.2M | $5.1M | $— | — |
| Q4 null | $180.9M | 47.5% | $-89.3M | $3.7M | $— | — |
| FY null | $701.2M | 49.8% | $-61.6M | $-67.9M | $— | — |
| Q3 null | $177.8M | 45.6% | $13.1M | $-1.4M | $— | — |
| Q2 null | $175.0M | 52.6% | $7.3M | $-76.8M | $— | — |
| Q1 null | $167.5M | 53.6% | $7.3M | $6.6M | $— | — |
| Q4 null | $179.6M | 55.3% | $12.5M | $-397.3M | $— | — |
| FY null | $687.8M | 55.4% | $40.0M | $-392.1M | $— | — |
| Q3 null | $170.4M | 54.5% | $16.7M | $4.3M | $— | — |
| Q2 null | $171.7M | 55.7% | $16.1M | $1.8M | $— | — |
| Q1 null | $166.1M | 57.1% | $7.4M | $-900.0K | $— | — |
| Q4 2023 | $173.3M | 54.8% | $22.2M | $10.5M | $0.23 | — |